Delivery Order SPE2DB22D2108-SPE2DB25FU3FN
Award Date
1/24/25
Potential Completion Date
1/27/25
Potential Value
$7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,065.93 firm fixed-price contract is for the supply of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML, a medical product, with a completion date of December 30, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML, a medical product, with a ceiling value of $3,595.76 and a performance period ending on December 21, 2023. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen Drug Corp holds a broader Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is a delivery order valued at $1,093.56 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML, a specialty medication, with an ultimate completion date of December 9, 2024. Amerisourcebergen, a for-profit organization, holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the...
This is a delivery order awarded to Amerisourcebergen Drug Corp (Corporate Office Division) by the Defense Logistics Agency (DLA) for the supply of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML, a pharmaceutical product. The contract has a firm fixed price ceiling value of $15,681.37 and a completion date of October 15, 2024. The award does not have a set-aside designation. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,270.29 firm fixed-price delivery order is for GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML medical supplies. The contract has a completion date of January 23, 2025 and was awarded on January 22, 2025. There is no set-aside designation for this contract, indicating it was openly competed. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
This is a delivery order under a longer-term Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,985.44 firm fixed-price contract is for the supply of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML, a medical product. The IDC has a ceiling value of $999,999,999 and runs through November 2026, providing a comprehensive range of pharmaceutical products and medical supplies to support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of GVOKE HYPOPEN 2PK 0.5MG/0.1 ML 0.1ML medical devices. The contract has a ceiling value of $1,601.25 and a completion date of February 4, 2025. It is a firm fixed-price Delivery Order contract, without any set-aside designation. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying...
This federal contract award, valued at $2,483.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML, a medical product. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
The federal contract award SPE2DX15D1053|SPE2DX25F6HRF was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,328.42 firm fixed-price delivery order contract is for the supply of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML medical products. This award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The contract, valued at $1,742.39, is a delivery order for GVOKE 1 MG/0.2 ML KIT 0.2ML, a pharmaceutical product. The contract has an ultimate completion date of October 16, 2024 and is a Firm Fixed Price contract. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal...